miRNA-642a-3p protects β cells from glucolipotoxicity
The incidence of type 2 diabetes mellitus (T2DM) is tightly linked to obesity. High levels of circulating glucose and saturated free fatty acids (FFAs), known as glucolipotoxicity (GLT), is implicated in β cell dysfunction and/or death. This study aims to identify miRNAs capable of protecting β cells from GLT-induced cell death (GICD). A library of 2,080 human miRNA mimics was transfected in β cells followed by exposure to GLT. We identified 45 miRNAs capable of protecting β cells from GICD and selected miR-642a-3p for further studies. RNA-seq revealed that miR-642a-3p restored the expression of β cell identity genes and modulated pathways associated with cell survival and lipid metabolism. Moreover, we showed that transfection of β cells with miR-642a-3p protected them from GLT-induced changes in insulin secretion. Compared with the control, hypercaloric-fed mice showed a trend toward decreased expression of GLT-protective miRNAs. Notably, we demonstrated that miR-642a-3p expression was downregulated in human islets isolated from T2DM patients compared with non-diabetic controls. Importantly, in obese patients, the expression of GLT-protective miRNAs in plasma-derived extracellular vesicles was increased in non-diabetic patients. Overall, we have identified a potential dual role for miR-642a-3p as both a biomarker and a facilitator of β cell survival and function, offering a novel theranostic tool for the management of diabetes and/or obesity.
Authors
- C. Henrique Alves (ORCID: https://orcid.org/0000-0001-9776-5701)
- Françoise Carlotti (ORCID: https://orcid.org/0000-0001-7929-8468)
- Cláudia M. Deus (ORCID: https://orcid.org/0000-0002-8344-9182)
- Twan J. J. de Winter (ORCID: https://orcid.org/0000-0001-7230-3674)
- Flávio Reis (ORCID: https://orcid.org/0000-0003-3401-9554)
- Martin Gotthardt (ORCID: https://orcid.org/0000-0002-6537-7744)
- Jorge Francisco Kuhn dos Santos (ORCID: https://orcid.org/0000-0001-7766-3513)
- John G. Jones (ORCID: https://orcid.org/0000-0002-3745-3885)
- Sofia Viana
- Joana Oliveira (ORCID: https://orcid.org/0000-0003-1864-8369)
- Sandra S. Pinhanços (ORCID: https://orcid.org/0000-0002-6748-5554)
- Mijke Buitinga (ORCID: https://orcid.org/0000-0002-4202-2473)
- Lino Ferreira (ORCID: https://orcid.org/0000-0001-8985-9302)
- Hugo Fernandes (ORCID: https://orcid.org/0000-0002-4574-7648)
Institutions
- Radboud University Nijmegen (NL)
- Universidade do Porto (PT)
- Leiden University Medical Center (NL)
- Maastricht University Medical Centre (NL)
- Radboud University Medical Center (NL)
- Polytechnic Institute of Coimbra (PT)
- Maastricht University (NL)
- Association for Innovation and Biomedical Research on Light and Image (PT)
- Centro Hospitalar do Porto (PT)
- University of Coimbra (PT)
Publication Details
- Journal
- Molecular Therapy — Nucleic Acids
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1016/j.omtn.2025.102498
- Citations
- 1
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Sociedade Portuguesa De Diabetologia
- European Commission
- ZonMw
- Ministério da Ciência, Tecnologia e Ensino Superior
- HORIZON EUROPE Framework Programme
- Fundação para a Ciência e a Tecnologia